Greenphire

Greenphire

Private
King of Prussia, PennsylvaniaEnterprise Softwarehttps://greenphire.com

Last Round

M&A

Apr 24, 2025

Est. Valuation

$1.1B

Total Funding Raised

$5.81M

Company Overview

Greenphire is a financial software company that provides a suite of solutions designed to automate and streamline the financial processes of clinical trials.

Sector

Enterprise Software

Verticals

Clinical Trials, Vertical SaaS, Accounting & Expense, Patient Engagement, Digital Payments

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee, Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

clinical trial paymentssite payment automationpatient reimbursementClinTechclinical trial financial managementinvestigator paymentscontract research organizationCROpatient travel logisticsclinical trial budgetingreloadable debit cardparticipant stipend managementfair market value analysispatient retention softwareCTMS integrationpatient cost data

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Greenphire Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Greenphire Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
M&AApr 24, 2025
M&AJul 12, 2021
Private EquityDec 19, 2014
Series A ExtensionSep 27, 2012
Series AAug 17, 2011

Key People

Founding team and executive leadership

John Samar

Chief Financial Officer Founder

Founding Team

Greenphire Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 31, 2025

    Budgeting and Data Analytics solution now available for clinical research sites.

Greenphire Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Greenphire Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Greenphire's valuation, stock price, and market status.

Firmographic Details

HeadquartersKing of Prussia, Pennsylvania
Employee Range233
Year Founded2008
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.